SomnoMed Limited
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more
SomnoMed Limited (SOMNF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.080x
Based on the latest financial reports, SomnoMed Limited (SOMNF) has a cash flow conversion efficiency ratio of 0.080x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.71 Million) by net assets ($46.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SomnoMed Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how SomnoMed Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
SomnoMed Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SomnoMed Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FIRST TIN PLC LS-001
F:1SN
|
N/A |
|
First Bankers Trustshares Inc
OTCQB:FBTT
|
N/A |
|
Signature Alliance Group Berhad
KLSE:0360
|
0.016x |
|
Kukje Pharma Co Ltd
KO:002720
|
0.052x |
|
Tifico Fiber Indonesia Tbk
JK:TFCO
|
0.000x |
|
PRL Global Ltd
AU:PRG
|
0.079x |
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
0.073x |
|
QS Energy Inc
PINK:QSEP
|
0.187x |
Annual Cash Flow Conversion Efficiency for SomnoMed Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of SomnoMed Limited from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $46.39 Million | $7.78 Million | 0.168x | +219.29% |
| 2024-06-30 | $45.02 Million | $-6.33 Million | -0.141x | +18.79% |
| 2023-06-30 | $22.40 Million | $-3.88 Million | -0.173x | -359.08% |
| 2022-06-30 | $27.79 Million | $1.86 Million | 0.067x | -20.55% |
| 2021-06-30 | $32.16 Million | $2.71 Million | 0.084x | -45.14% |
| 2020-06-30 | $33.84 Million | $5.19 Million | 0.153x | +141.74% |
| 2019-06-30 | $17.82 Million | $-6.55 Million | -0.367x | -27.15% |
| 2018-06-30 | $32.77 Million | $-9.47 Million | -0.289x | -233.80% |
| 2017-06-30 | $30.95 Million | $-2.68 Million | -0.087x | -234.43% |
| 2016-06-30 | $32.69 Million | $2.11 Million | 0.064x | +671.80% |
| 2015-06-30 | $21.51 Million | $-242.22K | -0.011x | +82.09% |
| 2014-06-30 | $12.57 Million | $-790.41K | -0.063x | -227.22% |
| 2013-06-30 | $11.57 Million | $572.00K | 0.049x | +52.14% |
| 2012-06-30 | $8.92 Million | $289.78K | 0.032x | +16.97% |
| 2011-06-30 | $6.22 Million | $172.68K | 0.028x | -65.99% |
| 2010-06-30 | $5.65 Million | $461.46K | 0.082x | +126.86% |
| 2009-06-30 | $4.33 Million | $-1.32 Million | -0.304x | +13.64% |
| 2008-06-30 | $6.01 Million | $-2.12 Million | -0.352x | +41.01% |
| 2007-06-30 | $3.91 Million | $-2.34 Million | -0.597x | +48.50% |
| 2006-06-30 | $3.23 Million | $-3.75 Million | -1.159x | -143.07% |
| 2005-06-30 | $7.20 Million | $-3.43 Million | -0.477x | -128.41% |
| 2004-06-30 | $-160.08K | $-268.63K | 1.678x | -- |